RPS6KA1 and melanoma: However, as S73/S409 are target sites for ERK‐/RSK1‐mediated phosphorylation, assessing the BAC transgenic mice in the context of deregulated MAPK signalling in an NRAS and/or BRAF mutant background will be of major importance and could reveal essential regulatory mechanisms relevant for melanoma.